|
⚲
|
| Keyboard |
| Marc Elia | |
|---|---|
| Firm | |
| Address | c/o M28 Capital Management LP 700 Canal Street, 2nd Floor Stamford, CT 06902 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Invivyd Inc | 021-466075 | Director | 23.7 M of 23.7 M |
||
| Fractyl Health Inc | 021-430685 | Director | 20.1 M of 20.1 M |
||
| Fractyl Health Inc | 021-403725 | Director | 100.0 M of 100.0 M |
||
| Adagio Therapeutics Inc | 021-380445 | Director | 80.0 M of 80.0 M |
||
| Adagio Therapeutics Inc | 021-380443 | Director | 49.9 M of 49.9 M |
||
| SQZ Biotechnologies Co | 021-368023 | Director | 66.3 M of 70.2 M |
||
| M28 Capital Master Fund LP | 021-363936 | Executive Officer | 0.2 M | ||
| M28 Capital Onshore Fund LP | 021-363933 | Executive Officer | 141.2 M | ||
| SQZ Biotechnologies Co | 021-354117 | Director | 71.3 M | ||
| M28 Capital Management LP | |||||
| Veltro Argento LP | 021-368671 | Executive Officer | 0.7 M | ||
| M28 Capital Master Fund LP | 021-363934 | Executive Officer | 14.2 M | 117.5 M | |